Skip to main content
Livermore
Livermore
ZHEN

Opus Capital Group, LLC

SEC CIK
0001330325
Latest filing
Jul 31, 2026

AVXL holding history

Anavex Life Sciences Corp. in every 13F filed by Opus Capital Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AVXL overviewAll 13F holders of AVXLFull Q2 2026 holdings

Shares (Q2 2026)
37,700
Value
$98.0K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of AVXL by Opus Capital Group, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202637,700$98.0K<0.1%00.0%UnchangedHolders
Q1 202637,700$116.0K<0.1%00.0%UnchangedHolders
Q4 202537,700$134.0K<0.1%+3,000+8.6%AddedHolders
Q3 202534,700$309.0K<0.1%00.0%UnchangedHolders
Q2 202534,700$320.0K<0.1%00.0%UnchangedHolders
Q1 202534,700$298.0K<0.1%00.0%UnchangedHolders
Q4 202434,700$373.0K<0.1%+2,000+6.1%AddedHolders
Q3 202432,700$186.0K<0.1%00.0%UnchangedHolders
Q2 202432,700$138.0K<0.1%+2,200+7.2%AddedHolders
Q1 202430,500$155.0K<0.1%00.0%UnchangedHolders
Q4 202330,500$284.0K<0.1%00.0%UnchangedHolders
Q3 202330,500$200.0K<0.1%+4,000+15.1%AddedHolders
Q2 202326,500$215.0K<0.1%00.0%UnchangedHolders
Q1 202326,500$227.0K<0.1%00.0%UnchangedHolders
Q4 202226,500$245.0K<0.1%+10,000+60.6%AddedHolders
Q3 202216,500$170.0K<0.1%00.0%UnchangedHolders
Q2 202216,500$165.0K<0.1%00.0%UnchangedHolders
Q1 202216,500$203.0K<0.1%00.0%UnchangedHolders
Q4 202116,500$286.0K0.1%00.0%UnchangedHolders
Q3 202116,500$296.0K0.1%+6,000+57.1%AddedHolders
Q2 202110,500$240.0K0.1%+500+5.0%AddedHolders
Q1 202110,000$150.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.